Guidance Promotes Uniformity in Clinical Evaluations
This article was originally published in The Gray Sheet
Executive Summary
The Global Harmonization Task Force's recently published 1final guidance on device clinical trial evaluations is intended to reduce regulators' frustrations with the process and improve the quality of evaluations worldwide